Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: Modulation by midazolam

European Neuropsychopharmacology

Volumn 20, Issue 6, 2010, Pages 388-397

  Bignante, Elena Anahi ^a   Paglini, Gabriela ^b   Molina, Victor Alejandro ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b INSTITUTO DE INVESTIGACIÓN MÉDICA MERCEDES Y MARTÍN FERREYRA   (Argentina)

Author keywords

Basolateral amygdala; Cdk5 p35; Emotional sensitization; Midazolam; Olomoucine; Stress

Indexed keywords

CYCLIN DEPENDENT KINASE 5; MIDAZOLAM; OLOMOUCINE; PROTEIN P53;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; EMOTIONALITY; ENZYME ACTIVITY; IMMOBILIZATION STRESS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; UPREGULATION;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CELL COUNT; CYCLIN-DEPENDENT KINASE 5; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12 SUBUNIT P35; KINETIN; MALE; MIDAZOLAM; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 77952542972     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.02.007     Document Type: Article

References (70)

1. Adamec R.E., Burton P., Shallow T., Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle - effective hemisphere depends on the behavior. Physiol. Behav. 1999, 65:739-751.
2. Adamec R.E., Blundell J., Burton P. Neural circuit changes mediating lasting brain and behavioral response to predator stress. Neurosci. Biobehav. Rev. 2005, 29:1225-1241.
3. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 1993, 16:328-333.
4. Albrechet-Souza L., Cristina de Carvalho M., Rodrigues Franci C., Brandão M.L. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm. Behav. 2007, 52:267-273.
5. Belda X., Rotllant D., Fuentes S., Delgado R., Nadal R., Armario A. Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann. N. Y. Acad. Sci. 2008, 1148:165-173.
6. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001, 410:376-380.
7. Bignante E.A., Rodriguez Manzanares P.A., Mlewski E.C., Bertotto M.E., Bussolino D.F., Paglini G., Molina V.A. Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stress. Eur. Neuropsychopharmacol. 2008, 18:578-588.
8. Calfa G., Volosin M., Molina V. Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav. Brain Res. 2006, 172:324-332.
9. Calfa G., Bussolino D., Molina V.A. Involvement of the lateral septum and the ventral Hippocampus in the emotional sequelae induced by social defeat: Role of glucocorticoid receptors. Behav. Brain Res. 2007, 181:23-34.
10. Cancela L.M., Volosin M., Molina V.A. Chronic stress attenuation of alpha 2-adrenoceptor reactivity is reversed by naltrexone. Pharmacol. Biochem. Behav. 1998, 31:33-35.
11. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 2002, 26:321-352.
12. Chae T., Kwon Y.T., Bronson R., Dikkes P., Li E., Tsai L.H. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18:29-42.
13. Cheung Z.H., Ip N.Y. The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2007, 2:949-957.
14. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1994, 49:171-176.
15. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
16. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 1992, 15:353-375.
17. Davis M. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur. J. NeuroSci. 2002, 16:395-398.
18. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry 2001, 6:13-34.
19. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
20. Dityatev A.E., Bolshakov V.Y. Amygdala, long-term potentiation, and fear conditioning. Neuroscientist 2005, 11:75-88.
21. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 1999, 23:743-760.
22. Fischer A., Sananbenesi F., Schrick C., Spiess J., Radulovic J. Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 2002, 22:3700-3707.
23. Fischer A., Sananbenesi F., Pang P.T., Tsai L.H. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 2005, 48:825-838.
24. Gray J.A., McNaughton N. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System 2000, Oxford University Press, Oxford. 2nd ed.
25. Harada T., Morooka T., Ogawa S., Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 2001, 3:453-459.
26. Hawasli A.H., Bibb J.A. Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol. J. 2007, 2:941-948.
27. Hawasli A.H., Benavides D.R., Nguyen C., Kansy J.W., Hayashi K., Chambon P., Greengard P., et al. Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 2007, 10:880-886.
28. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997, 20:78-84.
29. Holland P.C., Gallagher M. Amygdala circuitry in attentional and representational processes. Trends Cogn. Sci. 1999, 3:65-73.
30. Isoardi N.A., Bertotto M.E., Martijena I.D., Molina V.A., Carrer H.F. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs. Eur. J. NeuroSci. 2007, 26:1036-1044.
31. Korte S.M., De Boer S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur. J. Pharmacol. 2003, 463:163-175.
32. LeDoux J.E. Emotion, memory and the brain. Sci. Am. 1994, 270:50-57.
33. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
34. Lew J., Huang Q.Q., Qi Z., Winkfein R.J., Aebersold R., Hunt T., et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994, 371:423-426.
35. Li B.S., Sun M.K., Zhang L., Takahashi S., Ma W., Vinade L., et al. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12742-12747.
36. Martijena I.D., Calvo N., Volosin M., Molina V.A. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res. 1997, 752:136-142.
37. Martijena I.D., Rodriguez Manzanares P.A., Lacerra C., Molina V.A. Gabaergic modulation of the stress response in frontal cortex and amygdala. Synapse 2002, 45:86-94.
38. McGaugh J.L. Memory - a century of consolidation. Science 2000, 287:248-251.
39. McGaugh J.L., Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 2002, 12:205-210.
40. Mitra R., Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5573-5578.
41. Nguyen M.D., Larivière R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30:135-147.
42. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 1996, 10:816-825.
43. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna Pant H.C., Brady R.O., et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11173-11178.
44. Paglini G., Cáceres A. The role of the Cdk5-p35 kinase in neuronal development. Eur. J. Biochem. 2001, 268:1528-1533.
45. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Ferreira A., et al. Evidence for the participation of the neuron-specific Cdk5 activator p35 during laminin-enhanced axonal growth. J. Neurosci. 1998, 18:9858-9869.
46. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402:615-622.
47. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, 15-31. Academic Press, San Diego. Ed. 3.
48. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
49. Petrovich G.D., Swanson L.W. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res. 1997, 763:247-254.
50. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J. Neurosci. 2004, 24:3471-3479.
51. Refojo D., Echenique C., Müller M.B., Reul J.M., Deussing J.M., Wurst W., Sillaber I., et al. Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6183-6188.
52. Rodgers R.J., Cole J.C. Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. Eur. J. Pharmacol. 1994, 261:321-325.
53. Rodriguez Manzanares P.A., Isoardi N.A., Carrer H.F., Molina V.A. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J. Neurosci. 2005, 25:8725-8734.
54. Roozendaal B., McGaugh J.L. Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiol. Learn. Mem. 1997, 67:176-179.
55. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009, 10:423-433.
56. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003, 83:803-834.
57. Sanders S.K., Morzorati S.L., Shekhar A. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Res. 1995, 699:250-259.
58. Sandi C., Loscertales M., Guaza C. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur. J. NeuroSci. 1997, 9:637-642.
59. Sawchenko P.E., Brown E.R., Chan R.K., Ericsson A., Li H.Y., Roland B.L., Kovács K.J. The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog. Brain Res. 1996, 107:201-222.
60. Stam R., Bruijnzeel A.W., Wiegant V.M. Long-lasting stress sensitisation. Eur. J. Pharmacol. 2000, 405:217-224.
61. Takagi M., Yamamoto C. The long-lasting inhibition recorded in vitro from the lateral nucleus of the amygdala. Brain Res. 1981, 206:474-478.
62. Takahashi S., Ohshima T., Cho A., Sreenath T., Iadarola M.J., Pant H.C., Kim Y., et al. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1737-1742.
63. Tsai L.H., Delalle I., Caviness V.S., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994, 371:419-423.
64. Van Nobelen M., Kokkinidis L. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm. Neuroscience 2006, 137:707-716.
65. Veselỳ J., Havlicek L., Strnad M., Blow J.J., Donella-Deana A., Pinna L., et al. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 1994, 224:771-786.
66. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002, 22:6810-6818.
67. Vyas A., Pillai A.G., Chattarji S. Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience 2004, 128:667-673.
68. Wei F.Y., Tomizawa K., Ohshima T., Asada A., Saito T., Nguyen C., et al. Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 2005, 93:502-512.
69. Wiedenmayer C.P. Adaptations or pathologies? Long-term changes in brain and behavior after a single exposure to severe threat. Neurosci. Biobehav. Rev. 2004, 28:1-12.
70. Wu L.J., Ko S.W., Toyoda H., Zhao M.G., Xu H., Vadakkan K.I., Ren M., et al. Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice. PLoS ONE 2007, 2:e167.